We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pivotal trial of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from CMERC-HI.
- Authors
Lee, Chan Joo; Rim, Tyler Hyungtaek; Kang, Hyun Goo; Yi, Joseph Keunhong; Lee, Geunyoung; Yu, Marco; Park, Soo-Hyun; Hwang, Jin-Taek; Tham, Yih-Chung; Wong, Tien Yin; Cheng, Ching-Yu; Kim, Dong Wook; Kim, Sung Soo; Park, Sungha
- Abstract
Objective The potential of using retinal images as a biomarker of cardiovascular disease (CVD) risk has gained significant attention, but regulatory approval of such artificial intelligence (AI) algorithms is lacking. In this regulated pivotal trial, we validated the efficacy of Reti-CVD, an AI-Software as a Medical Device (AI-SaMD), that utilizes retinal images to stratify CVD risk. Materials and Methods In this retrospective study, we used data from the Cardiovascular and Metabolic Diseases Etiology Research Center-High Risk (CMERC-HI) Cohort. Cox proportional hazard model was used to estimate hazard ratio (HR) trend across the 3-tier CVD risk groups (low-, moderate-, and high-risk) according to Reti-CVD in prediction of CVD events. The cardiac computed tomography-measured coronary artery calcium (CAC), carotid intima-media thickness (CIMT), and brachial-ankle pulse wave velocity (baPWV) were compared to Reti-CVD. Results A total of 1106 participants were included, with 33 (3.0%) participants experiencing CVD events over 5 years; the Reti-CVD-defined risk groups (low, moderate, and high) were significantly associated with increased CVD risk (HR trend, 2.02; 95% CI, 1.26-3.24). When all variables of Reti-CVD, CAC, CIMT, baPWV, and other traditional risk factors were incorporated into one Cox model, the Reti-CVD risk groups were only significantly associated with increased CVD risk (HR = 2.40 [0.82-7.03] in moderate risk and HR = 3.56 [1.34-9.51] in high risk using low-risk as a reference). Discussion This regulated pivotal study validated an AI-SaMD, retinal image-based, personalized CVD risk scoring system (Reti-CVD). Conclusion These results led the Korean regulatory body to authorize Reti-CVD.
- Subjects
CAROTID intima-media thickness; CARDIOVASCULAR diseases; CORONARY artery calcification; PULSE wave analysis; PROPORTIONAL hazards models; NEW product development laws
- Publication
Journal of the American Medical Informatics Association, 2024, Vol 31, Issue 1, p130
- ISSN
1067-5027
- Publication type
Article
- DOI
10.1093/jamia/ocad199